Abstract
Background
Recent studies have suggested that Kawasaki disease (KD) may cause endothelial dysfunction, which can potentially induce atherosclerosis. However, there is still no consensus on the relationship between KD and atherosclerosis. This article aimed to determine whether patients with a history of KD may be at increased risk for accelerated atherosclerosis via a meta-analysis.
Methods
The PubMed, Embase, and SpringerLink databases were systematically searched. Studies on risk factors for atherosclerosis were included. A meta-analysis of case–control studies was performed using RevMan 5.3 software.
Results
Twenty studies were included with a total of 1684 subjects (990 patients after KD and 694 controls). The meta-analysis showed that the level of carotid intima-media thickness (cIMT) (95% CI: 0.01, 0.03; P = 0.005) and high-sensitivity C-reactive protein (hsCRP) (95% CI: 0.00, 0.10; P = 0.03) were significantly higher in patients after KD than controls, whereas flow-mediated dilatation (FMD) (95% CI: − 5.14, − 1.26; P = 0.001) in patients after KD was significantly lower. There were no significant differences in total cholesterol (TC) (95% CI: − 0.13, 5.92; P = 0.06), low-density lipoprotein cholesterol (LDL) (95% CI: − 0.65, 2.08; P = 0.31), or triglycerides (TG) (95% CI: − 1.94, 8.03; P = 0.23).
Conclusion
Endothelial dysfunction and inflammatory processes may exist in patients with a history of KD, which are risk factors for the development of atherosclerosis.
Similar content being viewed by others
Data availability statement
This article data are available to authorized users.
References
Sosa T, Brower L, Divanovic A. Diagnosis and management of Kawasaki disease. JAMA Pediatr. 2019;173:278–9.
Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22:79–85.
Meena RS, Rohit M, Gupta A, Singh S. Carotid intima-media thickness in children with Kawasaki disease. Rheumatol Int. 2014;34:1117–21.
Duan C, Du ZD, Wang Y, Jia LQ. Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease. World J Pediatr. 2014;10:232–7.
Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 16 Oct 2020.
Borzutzky A, Gutiérrez M, Talesnik E, Godoy I, Kraus J, Hoyos R, et al. High sensitivity c-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease. Clin Rheumatol. 2008;27:845–50.
Chen KY, Zannino D, Curtis N, Cheung M, Burgner D. Increased aortic intima-media thickness following Kawasaki disease. Atherosclerosis. 2017;260:75–80.
Cheung YF, Karmin O, Woo CWH, Armstrong S, Siow YL, Chow PC, et al. Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness. BMC Pediatr. 2008;8:20.
Cho HJ, Yang SI, Kim KH, Kim JN, Kil HR. Cardiovascular risk factors of early atherosclerosis in school-aged children after Kawasaki disease. Korean J Pediatr. 2014;57:217–21.
Dalla Pozza R, Bechtold S, Urschel S, Kozlik-Feldmann R, Netz H. Subclinical atherosclerosis, but normal autonomic function after Kawasaki disease. J Pediatr. 2007;151:239–43.
Dietz S, Tacke C, Gort J, Kuipers I, De Groot E, Wiegman A, et al. Carotid intimamedia thickness in patients with a history of Kawasaki disease. Circ J. 2015;79:2682–7.
Ghelani SJ, Singh S, Manojkumar R. Endothelial dysfunction in a cohort of North Indian children with Kawasaki disease without overt coronary artery involvement. J Cardiol. 2009;53:226–31.
Gopalan K, Singh S, Vignesh P, Gupta A, Rohit M, Attri SV. Carotid intima-media thickness and lipid profile in children with Kawasaki disease: a single-center follow-up study after a mean duration of 6.9 years. J Clin Rheumatol. 2018;24:385–9.
Gupta-Malhotra M, Gruber D, Abraham SS, Roman MJ, Zabriskie JB, Hudgins LC, et al. Atherosclerosis in survivors of Kawasaki disease. J Pediatr. 2009;155:572–7.
Ishikawa T, Iwashima S. Endothelial dysfunction in children within 5 years after onset of Kawasaki disease. J Pediatr. 2013;163:1117–21.
Laurito M, Stazi A, Delogu AB, Milo M, Battipaglia I, Scalone G, et al. Endothelial and platelet function in children with previous Kawasaki disease. Angiology. 2014;65:716–22.
Lee SJ, Ahn HM, You JH, Hong YM. Carotid intima-media thickness and pulse wave velocity after recovery from Kawasaki disease. Korean Circ J. 2009;39:264–9.
Liu XQ, Huang GY, Liang XV, Ma XJ. Endothelial progenitor cells and arterial functions in the late convalescence period of Kawasaki disease. Acta Paediatr. 2009;98:1355–9.
McCrindle BW, McIntyre S, Kim C, Lin T, Adeli K. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? J Pediatr. 2007;151:244–8 (248.e1).
Mitra A, Singh S, Devidayal, Khullar M. Serum lipids in North Indian children treated for Kawasaki disease. Int Heart J. 2005;46:811–7.
Niboshi A, Hamaoka K, Sakata K, Yamaguchi N. Endothelial dysfunction in adult patients with a history of Kawasaki disease. Eur J Pediatr. 2008;167:189–96.
Noto N, Okada T, Karasawa K, Ayusawa M, Sumitomo N, Harada K, et al. Age-related acceleration of endothelial dysfunction and subclinical atherosclerosis in subjects with coronary artery lesions after Kawasaki disease. Pediatr Cardiol. 2009;30:262–8.
Oguri M, Nakamura T, Tamanuki K, Akita C, Kitaoka C, Saikawa Y, et al. Subclinical arterial stiffness in young children after Kawasaki disease. Cardiol Young. 2014;24:87–94.
Parihar M, Singh S, Vignesh P, Gupta A, Rohit M. Mid-term risk for subclinical atherosclerosis and chronic myocarditis in children with Kawasaki disease and transient coronary abnormalities. Pediatr Cardiol. 2017;38:1123–32.
Selamet Tierney ES, Gal D, Gauvreau K, Baker AL, Trevey S, O’Neill SR, et al. Vascular health in Kawasaki disease. J Am Coll Cardiol. 2013;62:1114–21.
Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993–2000.
Aloi M, Tromba L, Rizzo V, D’Arcangelo G, Dilillo A, Blasi S, et al. Aortic intima-media thickness as an early marker of atherosclerosis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2015;61:41–6.
Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, et al. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension. 2009;54:919–50.
Geovanini GR, Libby P. Atherosclerosis and inflammation: overview and updates. Clin Sci (Lond). 2018;132:1243–52.
Zhang H, Xu MG, Xie LJ, Huang M, Shen J, Xiao TT. Meta-analysis of risk factors associated with atherosclerosis in patients with Kawasaki disease. World J Pediatr. 2016;12:308–13.
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–99.
Funding
This research was supported by the Specially Appointed Medical Expert Project of Jiangsu Commission of Health (2019) and the Medical Science and Technique Foundation of Nanjing Health Commission (YKK19104).
Author information
Authors and Affiliations
Contributions
Conceptualization: YYZ; writing—original draft preparation: YYZ and FC; writing—review and editing: YYZ, FC, XJ and YZ; funding acquisition: FC. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
Not needed for the meta-analysis.
Conflict of interest
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zeng, YY., Chen, F., Zhang, Y. et al. Are patients recovering from Kawasaki disease at increased risk for accelerated atherosclerosis? A meta-analysis. World J Pediatr 17, 476–483 (2021). https://doi.org/10.1007/s12519-021-00452-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-021-00452-x